World leader in preventive healthcare, Randox Health, is announced as the title sponsor of the 150th Anniversary celebrations for Royal Ulster Yacht Club at Bangor on Belfast Lough.
The fortnight of celebrations began on Friday 17th June with The Sigma 33 UK & Irish National Championships which attracted twenty boats from throughout the UK and Ireland. The 150th Keelboat event begins on Saturday 25th June until Sunday 26th June. This event has attracted not only local modern yachts but also some of the classics of the sport. The 150th Anniversary celebrations will conclude on Friday 1st July with a Gala Dinner.
Stuart Penrose, Global Marketing Manager of Randox Health is eagerly anticipating the 150th Keelboat event this weekend, and commented;
“We are proud to sponsor the Royal Ulster Yacht Club in its 150th year. As an innovative healthcare company committed to improving people’s health and wellbeing, we value the opportunity for people to get involved in competitive sport, that the RUYC offers. Sailing simultaneously brings benefits to your physical health, but getting out on the sea and taking in fresh air can contribute to your wellbeing too.”
The Randox Health team will also be in attendance at the event, where you can find information on the latest technology to better understand your current and future health.
Randox Health is committed to changing the landscape of preventative health care through a steadfast commitment to developing the most comprehensive and personalised health checks possible.
To find out more, contact the Randox Health team today:
0800 2545 130
Global innovative healthcare company, Randox Health, will become the new Official Partner of the world’s greatest race, the Grand National, and the three-day Grand National Festival staged at Aintree Racecourse.
Randox Health is a world leader in healthcare diagnostics; today more than 5% of the world’s population – in excess of 370 million people across 145 countries – receives medical diagnosis using Randox products each year.
Offering the world’s most advanced preventive health screening in their clinics, currently in London and Belfast, Randox Health plans to roll out clinics nationally and internationally over the next 12 months, including in Liverpool, Manchester, Edinburgh and Dublin. The Randox Health checks aim to prevent illness and enhance wellbeing by running hundreds of tests from one simple patient sample. These unique tests give an extraordinary insight into every aspect of a person’s health.
Founded in 1982 in County Antrim by leading medical scientist and keen horseman, Dr. Peter FitzGerald CBE, Randox Health is dedicated to improving health and enhancing lives, worldwide. To achieve their goals the company is committed to an extensive research programme, investing more than £220m since 1992. The company currently employs more than 1,400 people of 44 different nationalities.
This research has also led to the establishment of a number of successful subsidiary companies supporting forensic toxicology, food safety and veterinary care, as well as leading developments within the pharmaceutical industry.
With around 9 million people tuning in each year in the UK, the £1 million Grand National currently attracts one of the largest live TV audiences in sport and Channel 4’s largest audience of the year. From 2017, the first year with new partner Randox Health, the race will be broadcast on ITV. Worldwide the event attracts an estimated television audience of around 600 million, with more than 150,000 people enjoying the action live from Aintree Racecourse in Merseyside over the course of the three-day racing festival.
Randox Health also becomes the Official Healthcare Partner of The Jockey Club. Founded in 1750 and today British Racing’s largest commercial group, The Jockey Club runs many of the sport’s most iconic assets which as well as the Grand National Festival include the Cheltenham Festival, The Investec Derby Festival and The National Stud, with all profits going back into the sport thanks to being a company incorporated by Royal Charter.
Crabbie’s, Title Partner for the 2016 Grand National Festival being held 7th to 9th April and the previous two runnings, will retain its association with the Jump Racing spectacular, moving from 2017 to become sponsors of the Grade 1 Top Novices’ Hurdle on the Friday’s Ladies Day.
Dr. Peter FitzGerald CBE, Founder and Managing Director of Randox, said:
“The Randox Health team is extremely pleased to partner the world’s greatest race. The Grand National offers us a major public platform to raise awareness of preventative healthcare and to encourage people to take control of their health and wellbeing. We see this partnership as a natural fit, as both organisations invest heavily in the future and we aim to use our partnership to promote a positive lifestyle and to bring enjoyment to millions of people. We care about people’s health and this is the people’s race.
“Crabbie’s sponsorship of the Grand National will be a hard act to follow, but we look forward to rising to the challenge and sharing our vision for Randox Health further once the 2016 Crabbie’s Grand National has drawn to a close and our rights for the world’s greatest race come into effect.”
John Baker, North West Regional Director for Jockey Club Racecourses, who runs Aintree, said:
“I am delighted to welcome Randox Health as our new partner from after the 2016 Crabbie’s Grand National Festival. This is an incredibly exciting time to join forces with Randox because they are highly ambitious as a company and share our aspiration to promote the Grand National to the maximum number of people in the years ahead.
“We are already working closely with Randox Health and are excited both about their plans for the future and how they see the role of our partnership within that. Their vision, people and operation are very impressive, they love their racing and I am confident they will prove fantastic partners for our crown jewel.
“I should also like to thank Crabbie’s brand owner, Halewood International, and in particular Judy Halewood and Peter Eaton, for their very generous and beneficial support of the Crabbie’s Grand National these past three years. I am very pleased they will remain involved and associated with Aintree through sponsorship of the high value Grade 1 Top Novices’ Hurdle and of course before that the important 169th running of the world’s greatest steeplechase in April under their banner.”
For more information contact Randox PR on 028 9445 1016 or email email@example.com, or firstname.lastname@example.org
For further information on Randox Health, please visit www.randoxhealth.com
The hard work and expertise of Northern Ireland’s leading Healthcare professionals was formally acknowledged at the Clandeboye Lodge Hotel on the evening of Thursday 4th February, where the glamorous black tie Randox Health Healthcare Awards took place.
Following on from the huge success of the inaugural Healthcare Awards last year, the event returned to the atmospheric hotel, for another evening of celebration and entertainment.
With a high calibre of Northern Ireland’s top businesses and organisations, including Ulster University, The South Eastern Trust, The Belfast Trust, Lloyds Pharmacy, Healthcare Ireland, Boots, Hutchinson Care Homes, Vision Express, and Danske Bank, turning out in their finest to enjoy a drinks reception and dinner, the evening saw those within the industry rewarded for their skills in the wider healthcare sector.
Categories announced and presented by the BBC’s Noel Thompson over the course of the evening included: Optometry Practice of the Year, Dental Practice of the Year, Pharmacist of the Year, The Innovation Award, Training in Healthcare Award, Clinical Excellence Award, Care Home of the Year, Community Nurse of the Year and GP Practice of the Year.
Popular comedian Josh Daniels performed on the evening after a fast-paced Live Charity Auction managed by City Auction Group. All proceeds from the event were donated to Marie Curie Cancer Care.
Katie Coyle, Manager of Randox Health who sponsored the event, said: “We are proud to be sponsoring The Healthcare Awards, and to therefore be able to simultaneously recognise the hard work of healthcare professionals across Northern Ireland, and raise funds for the very worthy cause of Marie Curie Cancer Care. At Randox Health we believe our personalised health check is at the forefront of a new era of healthcare, and we subsequently recognise this dedication and commitment to improving healthcare in our peers who attended last night’s event. Congratulations to everyone who won an award – we are delighted that we were able to share in your success. ”
The awards ceremony paid tribute to healthcare professionals, in both the private sector and across the NHS, who showcase excellence in day-to-day patient care, patient service, innovation, surgery facilities and after-care, and who strive towards improving the quality of healthcare and the health of the region.
The Nurse of the Year Award, recognising the hard work of nurses across Northern Ireland who provide an invaluable 24 hours a day service to patients, was won by Michelle Doggett, acknowledging her high standard of patient care and management to her patients.
Donna Hosking, Event Organiser of The Healthcare Awards, was extremely pleased with how the evening went and emphasised that the competition for each category was fierce: “We are thrilled to have teamed up with Randox Health for this year’s awards to recognise and reward best practice in the healthcare sector, within medicine, pharmacy, nursing, community care, dentistry and research. The awards are now in their second year and have attracted a wide range of applicants from healthcare practices, businesses and consultancies from across Northern Ireland – all of whom are extremely successful healthcare professionals, worthy of winning an award for their hard work and dedication to improving health in Northern Ireland. On behalf of everyone who was involved in The Randox Health Healthcare Awards I would like to congratulate all of our award winners, and thank all of our attendees for supporting the event. To all of our awards applicants I would like to say thank you for your hard work in your respective fields, and I hope you enjoyed the evening!”
- UK-based diagnostics firm supporting call for responsible use of antibiotics in conjunction with European and International Antibiotics Awareness initiatives
- New molecular diagnostic multiplex assays hold the key to first-time, accurate diagnosis of infectious diseases
- Assays have the power to diagnose primary, secondary and asymptomatic co-infections to inform appropriate antibiotic prescribing
UK-based diagnostics company, Randox Laboratories, is supporting the call for patients and prescribers to ‘resist and desist’ antibiotic use in the fight against antimicrobial resistance this European Antibiotics Awareness Day. Coinciding with international awareness weeks in Australia, Canada and the USA, the concerted efforts of health authorities around the world to curb the spread of antimicrobial resistance is testimony to the global reach of the issue.
Now declared a ‘major threat’ by the World Health Organisation, Randox has been working at the forefront of this global challenge to deliver effective diagnostic solutions to arm against this growing problem. Developed over two decades of research and an investment of £200m, Randox’s innovative Biochip Array Technology (BAT) is the latest weapon in the fight against antimicrobial resistance, with the ability to simultaneously detect multiple pathogens in a single test for rapid and accurate diagnosis.
Randox’s range of molecular assays within infectious disease enable the detection of primary, secondary and asymptomatic co-infections for a more comprehensive understanding of the drivers of infection in individual patients. The Randox STI Multiplex Array simultaneously detects up to 10 pathogens from a single patient sample, whilst the Randox Respiratory Multiplex Array rapidly screens for 22 bacterial and viral upper and lower respiratory tract infections, with same day result reporting, for rapid diagnosis.
As Randox Managing Director Dr Peter FitzGerald CBE FREng explains, screening for all potential pathogens in infectious disease is vital in ensuring accurate diagnoses can be made; “Even after a confirmed diagnosis, many patients who haven’t been tested for a wider range of pathogens may harbour co-infections, impeding the effectiveness of therapeutic treatment and prolonging exposure to infection.
“Through a more comprehensive screening strategy at initial presentation, a complete patient profile can be obtained which will give clinicians greater understanding of the working of the disease and allow them to diagnose and prescribe correctly, ruling in or out the need for antibiotics, and helping to control their appropriate use.”
Antibiotic resistance has largely been fuelled by patient and prescriber overreliance on using antibiotics to treat disease. Once considered to be ‘magic bullets’ for curing infections, antibiotics are now firing blanks as they become ineffective against many common and treatable infectious diseases, such as the sexually transmitted infection, Neisseria gonorrhoeae, and respiratory tract infections such as staphylococcus aureus and streptococcus pneumoniae, which have been shown to be acquiring increasing levels of resistance to antibiotic treatment.
“First-time, accurate diagnosis of infection through molecular testing is key to treating infections correctly. The availability of these assays provides a powerful weapon in the fight against antimicrobial resistance and we would encourage health providers around the world to utilise this technology to help curb the spread of the problem.”
For more information visit Randox: www.randox.com.